Galanin Receptors as Drug Target for Novel Antidepressants: Review
Desalegn Getnet Demsie,1 Birhanetensay Masresha Altaye,2 Etsay Weldekidan,1 Hagazi Gebremedhin,1 Niguse Meles Alema,3 Mulugeta Mihrete Tefera,3 Abere Tilahun Bantie4 1College of Medicine and Health Sciences, Department of Pharmacy, Adigrat University, Adigrat, Ethiopia; 2College of Health Sciences,...
Guardado en:
Autores principales: | Demsie DG, Altaye BM, Weldekidan E, Gebremedhin H, Alema NM, Tefera MM, Bantie AT |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f7df9e2cd2024a7f855b56ad4fee7d18 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Potential role of galanine in the treatment of type 2 diabetes mellitus
por: Igor Vladimirovich Dobrokhotov, et al.
Publicado: (2020) -
Association Between Polymorphisms in the 5′ Region of the GALR1 Gene and Schizophrenia in the Northern Chinese Han Population: A Case–Control Study
por: Li Y, et al.
Publicado: (2020) -
Antidepressant effects of an inverse agonist selective for α5 GABA-A receptors in the rat forced swim test
por: Samardžić Janko, et al.
Publicado: (2014) -
Glycopeptides as Potential Interventions for COVID-19
por: Demsie DG, et al.
Publicado: (2020) -
Serotonin Type 6 and 7 Receptors as a Novel Therapeutic Target for the Treatment of Schizophrenia
por: Tsegay EW, et al.
Publicado: (2020)